|
|
|
- Raymond Arnold
- 8 years ago
- Views:
Transcription
1 Santaravalley: Integrating scientific research, high-tech business and academia Prof. Vladas Algirdas Bumelis President of Santara valley Association Vilnius, Lithuania 2013July 18 th Santara Valley Association 1
2 Agenda What is Santara valley? Integration of high-tech business and public research New developments in Santara valley in Lithuanian life science industry Asociacija Santaros slėnis 2
3 Agenda What is Santara valley? Integration of high-tech business and public research New developments in Santara valley in Lithuanian life science industry Asociacija Santaros slėnis 3
4 What is Santara valley? 1. Santarais a cluster of business, science and education institutions being developed on an integrated territory through State development program together with private investments 2. Santaraemerged as a competence centrein following science and technology areas: Biotechnology and biopharmaceuticals Innovative medicine technologies Ecosystems and sustainable development IT and clean-tech 3. Santarascientific research and high-tech industries generates about 4.4 percent of country s GDP 4. Santaravalley development program is executed by Ministry of Economy and Ministry of Science and Education with 73.2 MEUR of funds allocated to 7 projects Santara Valley Association 4
5 Santara valley association 1. Santaravalley association was established in 2010 to coordinate development of valley and create viable link between science and business 2. Santaravalley association consolidates more than 30 institutional members (direct or affiliated): Research institutes: Nature Research Centre, Innovative medicine centre, Biotechpharma Universities: Vilnius University, Vilnius Gediminas Technical University Vilnius Municipality and Visoriai Information Technology Park Medical centresand hospitals: SantariskesHospitals, Northway, Institute of Oncology High-tech Business: Pharmaceutical, IT and biotechnology companies 3. Ministry of Economy and Ministry of Science and Education directly participate in Santara valley strategic management on Board level Santara Valley Association 5
6 Agenda What is Santara valley? Integration of high-tech business and public research New developments in Santara valley in Lithuanian life science industry Asociacija Santaros slėnis 6
7 A balance between high-tech business and public research SicorBiotech (TEVA) production centre Technology park (VITP) Nature Research Institute Vilnius University faculty (IT) Biotech business INCUBATORS BIOTECHPHARMA R&D centre BOD Solar cells technology centre MOOG Medical Devices centre Medical research institute (IMC) Vilnius University Hospital Institute of Oncology - Public research and healthcare infrastructure - Private research and manufacturing infrastructure
8 Agenda What is Santara valley? Integration of high-tech business and public research New developments in Santara valley in Lithuanian life science industry Asociacija Santaros slėnis 8
9 New developments in Santara valley in Key infrastructure development projects: Innovative medicine centre (IMC) Biotechnology business incubator BIOTECHPHARMA private R&D centre MOOG Medical Devices development centre BOD Group production and technology centre Asociacija Santaros slėnis 9
10 Innovative medicine centre (IMC) The result of merger of two state owned research institutes with extensive track record in biomedical research: Regeneration medicine Immunodiagnostics and immunotherapy Biopharmaceuticals Innovative healthcare services development 15 MEUR capital investment to create modern research infrastructure: 8000 sq. m. building with open access laboratories Enabling new fields of cooperation with industry: Stem cells research Immunotechnology and Biomarker research Biopharmaceutical research and drug development Biomedical information systems development Biomodels development and preclinical research Digital and molecular pathology Santara Valley Association 10
11 Biotechnology business incubator Bio-business incubator will focus on biotechnology and biomedicine start-ups and facilitate use of common laboratory infrastructure in Santara valley Project partners are Innovative medicine centre, SantariskesHospitals and Association of innovative medicine and biopharmacy 2.8 MEUR investment will create more than 3000 sq. m. of bio-incubator space The project hastwosites SantariskesHospitals campus and Visoriaibusiness park to capture opportunities both in biotechnology and biomedicine areas and benefit from proximity of large research centres Santara Valley Association 11
12 BIOTECHPHARMA global biopharmaceutical services centre 22 MEUR investment to build contract R&D service centre for: development of recombinant protein technologies development of drug products for clinical research manufacturing of experimental drug products according to EU and US cgmp standards Biotechpharma is a globally competitive R&D service company Sales are dominated by R&D services export to global biotech and pharma companies Total sales are projected to grow from 2.7 MEUR to 22.5MEUR in Employee growth from 60 to 100 Biotechpharma was granted a private research institute status by Ministry of Science and Education in 2013 Santara Valley Association 12
13 BIOTECHPHARMA milestones 2004 BiotechpharmaUAB established as a proteomic research company in Vilnius, Lithuania 2007 Biotechpharma commenced biopharmaceuticalr&d activities and started to develop recombinant protein technologies 2011 new biopharmaceutical R&D center was opened for contract research and development services 2012 cgmp-compliant biopharmaceutical manufacturing facility was completed 2013 Multinational cooperation with biotech and pharm companies Asociacija Santaros slėnis 13
14 BIOTECHPHARMA field of expertise Biopharmaceutical manufacturing technology development Innovative and biosimilar products Material supply for Clinical Trials Proteins derived from bacterial and mammalian cell lines Analytical methods development Protein structure research Asociacija Santaros slėnis 14
15 MOOG Medical Devices global medtech development centre An investment of MOOG Corp. (USA) to establish global technology centre for development and manufacturing of medical devices: Core competences of the centrewas established through acquisition of Lithuanian medtech company UAB Viltechmeda Over 20 years the company became leader in medical devices R&D and manufacturing Viltechmeda syringe pumps are being widely accepted on global medical devices market This project was the first greenfield investment (FDI) project in Santara valley receiving financial support directly from Lithuanian government Currently, the company is aimed to reach 10 MEUR in export sales in 2013 and grow to over 100 employees Santara Valley Association 15
16 BOD Group high-tech business centre 36.0 MEUR investment to build up state-of-the-art technology centre: Solar energy cells and devices development and manufacturing Optical storage media manufacturing Digital content development and anti-piracy technology development BOD Group new centreis aimed to reach 49.0 MEUR sales in 2014 Together with BOD Group facilities other well known high-tech companies are moving to Santara valley territory: Molecular diagnostics company Sorpo Laser optics and optomechanicscompany Altechna Other technology companies: Kemek Engineering, Singulus Technologies AG Santara Valley Association 16
17 Agenda What is Santara valley? Integration of high-tech business and public research New developments in Santara valley in Lithuanian life science industry Asociacija Santaros slėnis 17
18 Life Sciences in Lithuania today Lithuania s life sciences industry demonstrate 22% annual growth within the biotechnology and pharmaceutical sectors Two decades of industrial leadership makes it the most advanced in Central and Eastern Europe Over80% of biotechnology production is exported to > 70 countries Annual average export growth 16.1% (average export growth of total Lithuanian origin goods 10.2%) Key strengths rely on competences in fields of: Pharmaceutical proteins Chemistry of enzymes and nucleic acids Regents and tools for molecular biology
19 Benchmark of Lithuanian biotechnology industry 10,0% Biotechnology input in Lithuanian GDP 1,0% 0,1% H E Target in % FR LT AT GR DE US UK BE EE NL NO LT CH IR FI DK S IT PT 0,0% Bio-Company number per capita 1 million
20 Strength of Lithuanian life science industry is in specialization and clusterization Santara Valley mission: To consolidate business, universities and public R&D efforts to execute integrated valley development program including development of R&D infrastructure, human resources and industrial research in biopharmaceutical and biomedicine areas Existing biopharmaindustry and global companies New biotechnology and biomedical products Applied research institute for biopharma R&D Company incubators and parks New biotech spin-off s Pre-clinical studies center
21 Thank you! Asociacija Santaros slėnis 21
Biotechpharma company profile
Biotechpharma company profile October 2013 1 History 2004 Biotechpharma UAB established as a proteomic research company in Vilnius, Lithuania 2005 Company became a member of UK s Northway group, investing
Join our scientific talent community
Join our scientific talent community There has never been a better time to be a part of Janssen Research & Development. We are at the forefront of healthcare leading, evolving and transforming it into
Our Competence to Your Business. 2014. MITA. All rights reserved.`````
Our Competence to Your Business ````` Open R&D Network in Lithuania The biggest excellence network of innovation infrastructure, services and competence in the Baltic countries A modern, operating open
BIOTECH MANUFACTURING SOLUTIONS 4 YOUR SUCCESS. a Novartis company
a Novartis company BIOTECH MANUFACTURING Sandoz GmbH Biotech Cooperations 6250 Kundl Austria Biochemiestrasse10 Phone +43 (0)5338 200 2609 Fax +43 (0)5338 200 442 biotech.cooperations@sandoz.com www.sandoz.com
NORTH CAROLINA STATE UNIVERSITY NORTH CAROLINA STATE UNIVERSITY Office of Technology Transfer
NORTH CAROLINA STATE UNIVERSITY Office of Technology Transfer putting ideas to work March 2007 Dr. Rob Whitehead Associate Director, Office of Technology Transfer March 2008 Research Extensive, Land-grant
RECOMMEND APPROVAL OF MASTER OF SCIENCE IN BIOMEDICAL SCIENCE AND BIOTECHNOLOGY AT UNIVERSITY OF COLORADO DENVER
Page 1 of 5 TOPIC: PREPARED BY: RECOMMEND APPROVAL OF MASTER OF SCIENCE IN BIOMEDICAL SCIENCE AND BIOTECHNOLOGY AT UNIVERSITY OF COLORADO DENVER IAN MACGILLIVRAY, DIRECTOR OF ACADEMIC AFFAIRS I. SUMMARY
Corporate Prospectus January 2015
Corporate Prospectus January 2015 1000 Morris Ave, STEM Bldg., Union, NJ 07083 Tel: (908) 737-1922 Fax: (908) 737-1924 www.ilsebio.com The Institute for Life Science Entrepreneurship (ILSE) is a regional
BIOTECHNOLOGY. about biotechnology
BIOTECHNOLOGY about biotechnology Introduction Biotechnology from humble beginnings based on fermentation processes used to make foods, alcoholic drinks, antibiotics and more recently, speciality chemicals
BIOTECHNOLOGY. Bouvé College of Health Sciences College of Science. Networked for Success. Networked for Industry. Networked for Life.
MASTER OF SCIENCE BIOTECHNOLOGY Networked for Success. Networked for Industry. Networked for Life. Bouvé College of Health Sciences College of Science Northeastern s Biotechnology Masters program synthesizes
From Research Services and Process Development to GMP Manufacturing
From Research Services and Process Development to GMP Manufacturing P a r ag o n B i o s e r v i c e s, I n c. A contract research and GMP manufacturing organization (CMO) with a focus on the development
PX Therapeutics : the partner for early stage biotherapeutics development Biotuesday, May 5 2009
PX Therapeutics : the partner for early stage biotherapeutics development Biotuesday, May 5 2009 Christelle Dagoneau, PhD Business Development Director Company Profile Protein expert incorporated in 2000
HU CZ FI PL SI PT IT ES NO NL FR DK SE IE GB AT DE CH LU 0 10 20 30 40 Foreigners' share Source: Eurostat More trust 3 4 5 6 7 PL HU CZ SI PT GR ES DK FI SE
Production in an Innovation Economy: The Globalization of Biomanufacturing and Implications for the Geography of Innovation
Production in an Innovation Economy: The Globalization of Biomanufacturing and Implications for the Geography of Innovation Industry Studies Association Pittsburgh, June 1, 2011 Elisabeth Reynolds, Ph.D.
1. What are the key strengths and weaknesses of the UK s innovation system in relation to business-university collaboration?
ABPI S RESPONSE TO THE BUSINESS, INNOVATION AND SKILLS SELECT COMMITTEE INQUIRY INTO THE STRENGTHS AND WEAKNESSES OF BUSINESS-UNIVERSITY COLLABORATION IN THE UK AND THE UK S PERFORMANCE AGAINST INTERNATIONAL
10/15/2012. Innovation, Translation, Impact. Quentin Pankhurst
Innovation, Translation, Impact Quentin Pankhurst A cross-faculty consortium for the promotion of innovative and translational research in medical technologies Medical Technologies Used to diagnose, monitor
BIOSCIENCES COURSE TITLE AWARD
COURSE TITLE AWARD BIOSCIENCES As a Biosciences undergraduate student at the University of Westminster, you will benefit from some of the best teaching and facilities available. Our courses combine lecture,
Czech Universities and the Environment for Innovation. Rudolf Hanka
Czech Universities and the Environment for Innovation Rudolf Hanka Czech Republic a cauldron of Central Europe? Geographical position Major motorways High speed backbone network Czech internet network
Master of Science in Biomedical Sciences
Master of Science in Biomedical Sciences Faculty of Medicine Good health is our greatest treasure. Understanding the human body, healthy and diseased, is the stepping stone to finding tools to improving
STW Open Technology Programme. H2020 Future & Emerging Technology. and. GRANTS WEEK 2015 October 9 th
STW Open Technology Programme and H2020 Future & Emerging Technology GRANTS WEEK 2015 October 9 th 9/12/2010 INDIVIDUAL FUNDING OPPORTUNITIES IN EUROPE 1 SUPPORT FOR RESEARCH FUNDING ACQUISITION AT THE
How To Get Involved In The Brussels Cluster
The Brussels Enterprise Agency & BEA Innovative Sectors dpt. The Brussels Enterprise Agency Outline BEA Innovative Sectors Department at a glance The Brussels Enterprise Agency (BEA) Regional development
Bioethics Education in Professional Science Master s Programs at California State University Channel Islands
ETHICS AND THE PSM Bioethics Education in Professional Science Master s Programs at California State University Channel Islands Ching-Hua Wang, M.D., Ph.D., Director of MS Biotechnology and Bioinformatics
Industry talent requirements and challenges reasons to stay strong in Medicon Valley
Industry talent requirements and challenges reasons to stay strong in Medicon Valley Peter Kurtzhals Senior Vice President, Diabetes Research Novo Nordisk The ability to attract talent in Denmark is key
THE BIOTECH & PHARMACEUTICAL INDUSTRY
THE BIOTECH & PHARMACEUTICAL INDUSTRY ESSENTIAL CAREERS INFORMATION CALUM LECKIE KATIE BISARO CAREERS CONSULTANTS What we will cover Sector overview Types of role Graduate recruitment trends and issues
Laboratory medicine as one of the pharmacists competencies
2014 EAFP Annual Conference Laboratory medicine as one of the pharmacists competencies Borut Božič Examinations of the body fluids in order to recognize the state of health of the individuals Greco-Roman
Master Degree in Pharmaceutical Biotechnologies
Master Degree in Pharmaceutical Biotechnologies Department of Pharmaceutical and Pharmacological Sciences University of Padova Via F. Marzolo 5, 35131 Padova 1 The purpose of the Master Degree in Pharmaceutical
LFB GROUP & SANOFI combine their bioproduction capabilities to provide integrated CMO services for biopharmaceuticals
LFB GROUP & SANOFI combine their bioproduction capabilities to provide integrated CMO services for biopharmaceuticals MAbLaunch TM is a joint bioproduction platform combining LFB Biomanufacturing (LFB
Company Presentation
Company Presentation DISCLAIMER This document contains forward-looking statements on overall economic development as well as on the business, earnings, financial and asset situation of amp biosimilars
LIFE SCIENCES QUEENSLAND LIMITED (LSQ) Mario Pennisi CEO. @LSQld
LIFE SCIENCES QUEENSLAND LIMITED (LSQ) Mario Pennisi CEO @LSQld LEADING DESTINATION FOR CLINICAL RESEARCH INVESTORS IN QLD INCLUDE: LIFE SCIENCES IN QLD ~300 companies in life sciences ~$5B invested by
The Myelin Repair Foundation: Accelerating New Treatments for Multiple Sclerosis and All Diseases. Scott Johnson CEO, President and Founder
The Myelin Repair Foundation: Accelerating New Treatments for Multiple Sclerosis and All Diseases Scott Johnson CEO, President and Founder Introduction Broken system of medical research No fault, system
LFB GROUP & SANOFI combine their bioproduction capabilities to provide integrated CMO services for biopharmaceuticals
LFB GROUP & SANOFI combine their bioproduction capabilities to provide integrated CMO services for biopharmaceuticals MAbLaunch TM is a joint bioproduction platform combining LFB Biomanufacturing (LFB
FACULTY OF ALLIED HEALTH SCIENCES
FACULTY OF ALLIED HEALTH SCIENCES 102 Naresuan University FACULTY OF ALLIED HEALTH SCIENCES has focused on providing strong professional programs, including Medical established as one of the leading institutes
Bayer Invests Heavily in R&D and is committed to innovation Sustained Innovation Output from all Subgroups
Open Innovation@BayerHealthCare Dr. Daniel Forler External Innovation Therapeutics Global Drug Discovery, Bayer HealthCare ASTP-Proton Conference Page 1 Bayer Invests Heavily in R&D and is committed to
Arizona and PSMs. Collaboration Across Arizona Universities for a Better Arizona
Arizona and PSMs Collaboration Across Arizona Universities for a Better Arizona Positioning Arizona and Its Research Universities: Science and Technology Core Competencies Assessment Battelle Based on
An Overview of the Life Sciences and Outsourcing Landscape in India: Spotlight on Bangalore
An Overview of the Life Sciences and Outsourcing Landscape in India: Spotlight on Bangalore A CanBiotech Report CanBiotech, 2007 1 An Overview of the Life Sciences and Outsourcing Landscape in India: Spotlight
MYRIAD, HITACHI, ORACLE & FRIEDLI JOIN FORCES TO MAP THE ENTIRE HUMAN PROTEOME
FOR IMMEDIATE RELEASE MYRIAD, HITACHI, ORACLE & FRIEDLI JOIN FORCES TO MAP THE ENTIRE HUMAN PROTEOME - $185 Million Collaboration to Determine All Human Protein Interactions And Decipher Biochemical Pathways
DOUBLE DEGREE MASTER PROGRAMMES
DOUBLE DEGREE MASTER PROGRAMMES Biotecnologie Sanitarie University of Udine, Udine, Italy (UNIUD) www.uniud.it Medical and Pharmaceutical Biotechnology IMC University of Applied Sciences, Krems, Austria
Medicines for Neglected Diseases Workshop. Dennis Liotta, Ph.D. Director Emory Institute for Drug Discovery Atlanta, Georgia
Medicines for Neglected Diseases Workshop Dennis Liotta, Ph.D. Director Emory Institute for Drug Discovery Atlanta, Georgia September 11, 2010 Poverty, Many People Poor health conditions High Morbidity
Curriculum Vitae. Prof. Dr. Bernhard Kutscher, Ph.D. Personal Details. Education
Curriculum Vitae Prof. Dr. Bernhard Kutscher, Ph.D. Personal Details Private Address: Date, Place of Birth: Marital Status: Nationality: Languages: Stresemannstraße 9, 93477 Maintal, Germany, Tel. +49
The majority of pharmaceutical companies in
Pharmaceutical Infrastructure and Industry Professor Che-Ming Teng, Ph.D. National Taiwan University College of Medicine, Taipei, Taiwan The majority of pharmaceutical companies in Taiwan are devoted to
PRODUCT CLASSIFICATION FOR ACCOUNTING, BOOKKEEPING AND AUDITING SERVICES; TAX CONSULTANCY SERVICES AND BUSINESS AND MANAGEMENT CONSULTANCY SERVICES
PRODUCT CLASSIFICATION FOR ACCOUNTING, BOOKKEEPING AND AUDITING SERVICES; TAX CONSULTANCY SERVICES AND BUSINESS AND MANAGEMENT CONSULTANCY SERVICES RELEVANCE TEST BASED ON DATA COLLECTED IN THE EU AND
Perspectives of the marine and maritime open access research infrastructure development in Lithuania
Perspectives of the marine and maritime open access research infrastructure development in Lithuania Saulius Gulbinskas, Asta Raugalienė Association Baltic Valley, Klaipeda Are EU innovation and research
The Sage Group and Talentmark Consulting Announce Strategic Alliance for Services to the Global Healthcare & Life Sciences Industry
Talentmark Consulting Product Driven People Solutions Press Release The Sage Group and Talentmark Consulting Announce Strategic Alliance for Services to the Global Healthcare & Life Sciences Industry Cambridge
General Legal Service Provider Information Form
General Legal Service Provider Information Form General information Name of Organisation LK Shields Solicitors Contact information Head of Organisation: Hugh Garvey (Managing Partner) Name: LK Shields
FedEx HealthCare Solutions. Supporting the global healthcare industry
FedEx HealthCare Solutions Supporting the global healthcare industry Today s Agenda Industry Trends Supply Chain Implications FedEx HealthCare Solutions Q&A 2 The HealthCare Industry is at a Critical Development
Selvita Integrated drug discovery collaborations
Selvita Integrated drug discovery collaborations Magdalena Żabka Selvita overview Origins Polish biotechnology research company headquartered in Krakow Mission Resources We deliver comprehensive solutions
Faculty of Applied Sciences. Bachelor s degree programme. Nanobiology. Integrating Physics with Biomedicine
Faculty of Applied Sciences Bachelor s degree programme Nanobiology Integrating Physics with Biomedicine We have just begun to explore life on this level Nanobiology uses the language of maths in the context
Avacta Group plc! Innovation for global health! Interim Results! 25th April 2012!
Avacta Group plc Innovation for global health Interim Results 25th April 2012 Important Notice This presentation does not constitute a recommendation regarding the shares of Avacta Group plc (the Company
Anforderungen der Life-Science Industrie an die Hochschulen. Hans Widmer Novartis Institutes for BioMedical Research
Anforderungen der Life-Science Industrie an die Hochschulen Hans Widmer Novartis Institutes for BioMedical Research There s nothing more extraordinary than a normal life 2 What does industry expect from
BACHELOR OF SCIENCE IN MICROBIOLOGY
BACHELOR OF SCIENCE IN MICROBIOLOGY The goal of the B.S. Microbiology program at Albany College of Pharmacy and Health Sciences is to prepare graduates for employment or advanced study in fields requiring
Molecular Biotechnology Master s Degree Program
> APPLIED LIFE SCIENCES Master s Degree Program: > FULL TIME Molecular Biotechnology Master s Degree Program www.fh-campuswien.ac.at My Occupational Future. Your Career Opportunities Biotechnology is one
Profile of Biomedical Research and Biotechnology Commercialization. San Francisco Oakland San Jose Consolidated Metropolitan Statistical Area
Profile of Biomedical Research and Biotechnology Commercialization San Oakland San Jose Consolidated Metropolitan Statistical Area Overview and History of Biotechnology in San The San Bay area is in many
Catalent Biologics & Clinical Supplies The SMART Solution
Catalent Biologics & Clinical Supplies The SMART Solution Advanced Technology and Integrated Solutions From DNA to Clinical Supply & Cold Chain Distribution Dr. Florian Schwaak Account Manager Germany
CALIFORNIA STATE UNIVERSITY CHANNEL ISLANDS
CALIFORNIA STATE UNIVERSITY CHANNEL ISLANDS PROGRAM MODIFICATION DATE: 12.06.06 PROGRAM AREA: BIOLOGY AND BUSINESS AND ECONOMICS SEMESTER /YEAR FIRST EFFECTED: FALL 2007 Please use the following format
Eden Biodesign ebook Monoclonal Antibody Production: Building the Platform
Eden Biodesign ebook Monoclonal Antibody Production: Building the Platform CHAPTER 1: Overview CHAPTER 2: Challenges CHAPTER 3: Purification Methodology CHAPTER 4: Results CHAPTER 5: About Eden Biodesign
Clinical Trial Trends Outline Complexity for Supply Chain. Scott Ohanesian, VP Commercial Operations APAC Email: Scott.Ohanesian@marken.
Clinical Trial Trends Outline Complexity for Supply Chain Scott Ohanesian, VP Commercial Operations APAC Email: Scott.Ohanesian@marken.com 29 May 2013 Biotechnology Sales on the Rise Source: EvaluatePharma
Biopharm Roundtable. 1. What, in your opinion, is currently the single largest trend with respect to biopharmaceutical outsourcing and manufacture?
BIOPHARM ROUNDTABLE Biopharm Roundtable Morrey Atkinson Vice President, R&D Cook Pharmica Peter Soelkner Managing Director Vetter Pharma-Fertigung GmbH & Co. KG Johannes Reiter Cooperations Manager Sandoz
COHESION POLICY: STRATEGIC REPORT 2013
COHESION POLICY: STRATEGIC REPORT 2013 Factsheet: Innovation and RTD investments Cohesion Policy EN Strategic Report 2013 Programme implementation 2007-2013 Factsheet: Innovation and RTD investments This
Automating Cell Biology Annual general meeting, September 7, 2015. Phase Holographic Imaging www.phiab.se
Automating Cell Biology Annual general meeting, September 7, 2015 www.phiab.se 1 PHASE HOLOGRAPHIC IMAGING (PHI) Began as a research project at Lund University, Sweden, in 2000 Founded in 2004 Sales in
BRISBANE TECHNOLOGY PARK
Gill Laird-Portch Manager, Brisbane Technology Park Overview Brisbane Technology Park (BTP), an established initiative of the Queensland Government s Smart State program, offers a unique and vibrant location
BioForum 2012 Central European Forum of Biotechnology and Innovative BioEconomy 23rd-24th May 2012, Brno Date & Venue Date Venue
BioForum 2012 Central European Forum of Biotechnology and Innovative BioEconomy 23 rd -24 th May 2012, Brno www.cebioforum.com Author: Edyta Wodzińska Bio-Tech Consulting 1 Date & Venue Date: May 23 rd
MSc program Pharmaceutical Design and Engineering. Peter Heegaard, Head of Studies DTU Veterinary
MSc program Peter Heegaard, Head of Studies DTU Veterinary There is a need for Pharma graduates Pharma industry in its widest sense (see next slide) Research institutions (public and private) Consultants
Background: Pathways for the Master s Degree (Thesis and Non Thesis)
Differences between the Non Thesis (Project) and Thesis Options for the M.S. in Pharmacy with an emphasis in BioPharma Regulatory Affairs Offered by the University of Georgia College of Pharmacy Background:
Building innovative drug discovery alliances. Addressing causes not. symptoms in diabetes
Building innovative drug discovery alliances Addressing causes not symptoms in diabetes Evotec AG, Analyst information on CureBeta Alliance with Janssen, Hamburg, 2012 Forward-looking statements Information
OFFICE OF INTERNATIONAL BUSINESS DEVELOPMENT PENNSYLVANIA S INNOVATION ECOSYSTEMS AND OPPORTUNITIES FOR CLUSTER COOPERATION
OFFICE OF INTERNATIONAL BUSINESS DEVELOPMENT PENNSYLVANIA S INNOVATION ECOSYSTEMS AND OPPORTUNITIES FOR CLUSTER COOPERATION Where is Pennsylvania? PA is located within 500 miles of: 40% of the U.S. population
Janssen Research & Development 3210 Merryfield Row San Diego, CA 92121
NHLBI SAN DIEGO INNOVATION CONFERENCE JUNE 11, 2013 Janssen Research & Development 3210 Merryfield Row San Diego, CA 92121 Agenda Speaker Bios 10:30-11:00 a.m. Registration 11:00-11:15 a.m. Welcome Remarks
Medical & Health Sciences
School of Postgraduate Studies Medical & Health Sciences (MSc /PhD by Research) 2016 What Is IMU s Medical & Health Sciences (by Research) Programme About? Overview Postgraduate research forms a major
Karel Klusacek Technology Centre AS CR, Prague, Czech Republic klusacek@tc.cz
CZECH TECHNOLOGY BUSINESS INCUBATORS-OPPORTUNITIES FOR R&D COLLABORATION AND JOINT VENTURES Karel Klusacek Technology Centre AS CR, Prague, Czech Republic klusacek@tc.cz Background Small and medium enterprises
SAN DIEGO S CLEANTECH INDUSTRY AT A GLANCE
Cleantech Editor s Note: The San Diego Regional Economic Development Corporation (EDC) would like to credit CleanTech San Diego as the principal contributor to the following industry overview. CleanTech
Faculty of of Science
Faculty of of Science At Ryerson, we believe science is all about discovery and results. We call our approach connected science an approach that forms unique bonds between disciplines to solve some of
Agenda Item 3. Discovery to Product Accelerator
Agenda Item 3 Discovery to Product Accelerator BOARD OF REGENTS SUMMARY OF ITEM FOR ACTION INFORMATION OR DISCUSSION TOPIC: Discovery to Product Accelerator (information item) COMMITTEE: Economic Development
Presented at: Jefferies 2015 Global Healthcare Conference
Presented at: Jefferies 2015 Global Healthcare Conference Agenda 1 Overview & Service Platforms 2 Adaptability, Scalability & Expansion Plans 3 Best Practices 4 Blue Chip Customer Base 5 Roadmap of Evolution
The College of Science Graduate Programs integrate the highest level of scholarship across disciplinary boundaries with significant state-of-the-art
GRADUATE PROGRAMS The College of Science Graduate Programs integrate the highest level of scholarship across disciplinary boundaries with significant state-of-the-art research centers and experiential
Outlook of China Biopharmaceutical Outsourcing Market
中 国 生 物 医 药 外 包 市 场 前 景 分 析 Outlook of China Biopharmaceutical Outsourcing Market JZMed, Inc. Report Description Attracted by the fast growth of the Chinese biopharmaceutical market as well as the thriving
The Postgraduate Course Toxicology Vienna
The Postgraduate Course Toxicology Vienna Completion as Master of Science (Toxicology) Beginning of next course: Summer term 2016 OPEN FOR REGISTRATION AT ANY TIME Contents: History Objectives Participants
BIO-PARTNERING EUROPE EVENT SPEECH PAOLA TESTORI COGGI DIRECTOR GENERAL FOR HEALTH AND CONSUMERS EUROPEAN COMMISSION
EUROPABIO BIO-PARTNERING EUROPE EVENT TUESDAY 9 OCTOBER 2012 9.10 9.20 HRS SPEECH BY PAOLA TESTORI COGGI DIRECTOR GENERAL FOR HEALTH AND CONSUMERS EUROPEAN COMMISSION I am pleased to have the opportunity
THE LINCOLN INSTITUTE OF HEALTH
THE LINCOLN INSTITUTE OF HEALTH Background The Chair in the Care of the Older Person will be part of the new Lincoln Institute of Health, a cross disciplinary research collaboration linking schools, colleges
1) SCOPE OF THE PROGRAM
CALL FOR PROJECTS 2015/16 CANADA/GERMANY JOINT PROGRAM DEADLINE: 15 TH JANUARY 2016 1) SCOPE OF THE PROGRAM The main goal of the Canada/Germany joint program is to strengthen research in Canada and Germany
Globala trender med lokala effekter
Globala trender med lokala effekter Den svenska Life Science industrin 1998-212 5 Mars kl. 8.3-1. Jenni Nordborg Göran Andersson Anna Sandström Life Sciences evolutionary and iterative innovation processes
Life Sciences Outlook United Kingdom. 2012
Life Sciences United Kingdom. 202 United Kingdom clusters driving scientific innovation Cambridge A leading cluster rooted around the namesake university South East of England A mature cluster with proximity
Course Curriculum for Master Degree in Medical Laboratory Sciences/Clinical Biochemistry
Course Curriculum for Master Degree in Medical Laboratory Sciences/Clinical Biochemistry The Master Degree in Medical Laboratory Sciences /Clinical Biochemistry, is awarded by the Faculty of Graduate Studies
Battelle Battelle s Technology Partnership Practice (TPP) Pharmaceutical Research and Manufacturers of America (PhRMA)
Every day, the people of Battelle apply science and technology to solving what matters most. At major technology centers and national laboratories around the world, Battelle conducts research and development,
Contents. Page 1 of 21
Programme-specific Section of the Curriculum for the MSc Programme in Biochemistry at the Faculty of Science, University of Copenhagen 2009 (Rev. 2015) Contents... 1 1 Title, affiliation and language...
MediSapiens Ltd. Bio-IT solutions for improving cancer patient care. Because data is not knowledge. 19th of March 2015
19th of March 2015 MediSapiens Ltd Because data is not knowledge Bio-IT solutions for improving cancer patient care Sami Kilpinen, Ph.D Co-founder, CEO MediSapiens Ltd Copyright 2015 MediSapiens Ltd. All
The Biotechnology Program at Montgomery College. Presented by Dr. Sanjay Rai Interim Vice President and Provost Germantown Campus Montgomery College
The Biotechnology Program at Montgomery College Presented by Dr. Sanjay Rai Interim Vice President and Provost Germantown Campus Montgomery College Biotechnology Meeting the demand for a skilled workforce
What Lies Ahead? Trends to Watch: Health Care Product Development in North America
What Lies Ahead? Trends to Watch: Health Care Product Development in North America What Lies Ahead? for 2015 DIA has released its third annual What Lies Ahead? report, providing experts insights into the
Project Management. Dissemination and Exploitation Services in Horizon 2020
Project Management Dissemination and Exploitation Services in Horizon 2020 Ontwerp: Studio Edwin de Boer 2 Project Management Dissemination and Exploitation Services in Horizon 2020 ttopstart - Project
New Jersey Bio-Pharmaceutical Life Sciences Landscape
New Jersey Bio-Pharmaceutical Life Sciences Landscape Prepared By: John Ehret Labor Market Analyst New Jersey Department of Labor & Workforce Development Division of Labor Market & Demographic Research
The Greater Zurich Area is Well-positioned in the Life Sciences in Switzerland and Europe
858 CHIMIA 214, 68, Nr. 12 Life ScienceS START-UPS in SwiTzeRLAnd doi:1.2533/chimia.214.858 Chimia 68 (214) 858 862 Schweizerische Chemische Gesellschaft The Greater Zurich Area is Well-positioned in the
Jeff Wolf Deputy Director HPC Innovation Center
Public Presentation for Blue Gene Consortium Nov. 19, 2013 www.hpcinnovationcenter.com Jeff Wolf Deputy Director HPC Innovation Center This work was performed under the auspices of the U.S. Department
PROMETIC LIFE SCIENCES INC.
PROMETIC LIFE SCIENCES INC. Investor Update July to September 2002 This present release must be considered as the quarterly report to shareholders. 1. Letter to Shareholders Dated November 21, 2002 2.
Biotechnology and Life Science Marketing Services Mailing List and Data Card Order Form
C H I Cambridge Healthtech Institute s Biotechnology and Life Science Marketing Services Mailing List and Data Card Order Form Over 800,000 names segmented by scientific interest Featuring U.S and International
SIPBS Portfolio. 2012-13 Entry
SIPBS Portfolio 2012-13 Entry MSc Programmes Existing: MSc Pharmaceutical Analysis MSc Analysis of Medicines (distance learning) MSc Clinical Pharmacy New Programmes just launched for Sept 2012 entry:
Department of Information Technology and Electrical Engineering. Master. Biomedical Engineering
Department of Information Technology and Electrical Engineering Master Biomedical Engineering Welcome The Master of Science in Biomedical Engineering at the ETH Zurich in Switzerland was created to meet
1. Program Title Master of Science Program in Biochemistry (International Program)
1 Program Structure and Specification Master of Science Program in Biochemistry (International Program) Curriculum Last Revised in 2012 for Students Entering in Academic Year 2016 -----------------------------------------
University of Medicine and Dentistry of New Jersey (UMDNJ)
University of Medicine and Dentistry of New Jersey (UMDNJ) Dual-Degree Program between the UMDNJ Graduate School of Biomedical Sciences (GSBS) And the UMDNJ School of Public Health (SPH) Leading to the:
Centre for Entrepreneurship. Master of Science in. Innovation and. graduate
Centre for Entrepreneurship Master of Science in Innovation and Entrepreneurship graduate Prospectus WELCOME WELCOME Contents The University of Oslo Students currently studying at the Centre for Entrepreneurship
Hong Kong Poised to be the Asia s Biotechnology Hub
Think Asia, think Hong Kong - London 13-09-2011 www.hkbio.org.hk BioTech at Science Park Your Safe and Fast Track to China Hong Kong Poised to be the Asia s Biotechnology Hub Albert Cheung Hoi Yu, Ph.D.
GMP Pharma BV. Netherlands
GMP Pharma BV Netherlands Connecting the European & Indian Pharmaceutical, Biotechnology and Biopharmaceutical Industry for parallel growth and solicitation. About Us: GMP Pharma BV is a multisource organization
MASTER OF PHILOSOPHY IN BIOSCIENCE ENTERPRISE
University of Cambridge: Programme Specifications Every effort has been made to ensure the accuracy of the information in this programme specification. Programme specifications are produced and then reviewed
Degrees in Science (& Physics)
Degrees in Science (& Physics) NUI, Galway College of Science National University of Ireland, Galway Revised January 2008 3 The world has changed...it has become FLAT! Geography no longer matters. Three